Form 8-K - Current report:
SEC Accession No. 0001493152-25-021567
Filing Date
2025-11-10
Accepted
2025-11-10 17:22:49
Documents
14
Period of Report
2025-11-04
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41266
2 EX-4.1 ex4-1.htm EX-4.1 304507
3 GRAPHIC ex4-1_001.jpg GRAPHIC 32479
  Complete submission text file 0001493152-25-021567.txt   624114

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ppcb-20251104.xsd EX-101.SCH 3011
5 XBRL LABEL FILE ppcb-20251104_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ppcb-20251104_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3779
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-42806 | Film No.: 251467455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)